These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 32356026

  • 1. In vitro activity of omadacycline against pathogens isolated from Mainland China during 2017-2018.
    Dong D, Zheng Y, Chen Q, Guo Y, Yang Y, Wu S, Zhu D, Deng D, Bradford PA, Reinhart H, Hu F.
    Eur J Clin Microbiol Infect Dis; 2020 Aug; 39(8):1559-1572. PubMed ID: 32356026
    [Abstract] [Full Text] [Related]

  • 2. Antimicrobial Activity of Omadacycline Tested against Clinical Bacterial Isolates from Hospitals in Mainland China, Hong Kong, and Taiwan: Results from the SENTRY Antimicrobial Surveillance Program (2013 to 2016).
    Carvalhaes CG, Huband MD, Reinhart HH, Flamm RK, Sader HS.
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30617092
    [Abstract] [Full Text] [Related]

  • 3. Surveillance of omadacycline activity tested against clinical isolates from the United States and Europe: Results from the SENTRY Antimicrobial Surveillance Programme, 2017.
    Huband MD, Pfaller MA, Shortridge D, Flamm RK.
    J Glob Antimicrob Resist; 2019 Dec; 19():56-63. PubMed ID: 30825698
    [Abstract] [Full Text] [Related]

  • 4. Antimicrobial activity of omadacycline in vitro against bacteria isolated from 2014 to 2017 in China, a multi-center study.
    Xiao M, Huang JJ, Zhang G, Yang WH, Kong F, Kudinha T, Xu YC.
    BMC Microbiol; 2020 Nov 16; 20(1):350. PubMed ID: 33198626
    [Abstract] [Full Text] [Related]

  • 5. Activities of Omadacycline and Comparator Agents against Staphylococcus aureus Isolates from a Surveillance Program Conducted in North America and Europe.
    Pfaller MA, Rhomberg PR, Huband MD, Flamm RK.
    Antimicrob Agents Chemother; 2017 Mar 16; 61(3):. PubMed ID: 27993854
    [Abstract] [Full Text] [Related]

  • 6. Surveillance of Omadacycline Activity against Clinical Isolates from a Global Collection (North America, Europe, Latin America, Asia-Western Pacific), 2010-2011.
    Pfaller MA, Huband MD, Rhomberg PR, Flamm RK.
    Antimicrob Agents Chemother; 2017 May 16; 61(5):. PubMed ID: 28223386
    [Abstract] [Full Text] [Related]

  • 7. In vitro and in vivo antibacterial activities of omadacycline, a novel aminomethylcycline.
    Macone AB, Caruso BK, Leahy RG, Donatelli J, Weir S, Draper MP, Tanaka SK, Levy SB.
    Antimicrob Agents Chemother; 2014 May 16; 58(2):1127-35. PubMed ID: 24295985
    [Abstract] [Full Text] [Related]

  • 8. Surveillance of Omadacycline Activity Tested against Clinical Isolates from the United States and Europe: Report from the SENTRY Antimicrobial Surveillance Program, 2016 to 2018.
    Pfaller MA, Huband MD, Shortridge D, Flamm RK.
    Antimicrob Agents Chemother; 2020 Apr 21; 64(5):. PubMed ID: 32071045
    [Abstract] [Full Text] [Related]

  • 9. Activity of Omadacycline and Other Tetracyclines Against Contemporary Gram-Negative Pathogens from New York City Hospitals.
    Iregui A, Landman D, Quale J.
    Microb Drug Resist; 2021 Feb 21; 27(2):190-195. PubMed ID: 32580619
    [Abstract] [Full Text] [Related]

  • 10. Surveillance of Omadacycline Activity Tested against Clinical Isolates from the United States and Europe as Part of the 2016 SENTRY Antimicrobial Surveillance Program.
    Pfaller MA, Huband MD, Shortridge D, Flamm RK.
    Antimicrob Agents Chemother; 2018 Apr 21; 62(4):. PubMed ID: 29378719
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The pharmacokinetic evaluation of omadacycline (Oral Only Dosing Regimen) for the treatment of Community-Acquired Bacterial Pneumonia (CABP).
    Cilloniz C, Torres A.
    Expert Opin Drug Metab Toxicol; 2023 Sep 21; 19(9):569-576. PubMed ID: 37728376
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Antimicrobial activity of the pleuromutilin antibiotic BC-3781 against bacterial pathogens isolated in the SENTRY antimicrobial surveillance program in 2010.
    Paukner S, Sader HS, Ivezic-Schoenfeld Z, Jones RN.
    Antimicrob Agents Chemother; 2013 Sep 21; 57(9):4489-95. PubMed ID: 23836172
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Bacterial susceptibility in bloodstream infections: Results from China Antimicrobial Resistance Surveillance Trial (CARST) Program, 2015-2016.
    Zhang F, Li Y, Lv Y, Zheng B, Xue F.
    J Glob Antimicrob Resist; 2019 Jun 21; 17():276-282. PubMed ID: 30611932
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Omadacycline: development of a novel aminomethylcycline antibiotic for treating drug-resistant bacterial infections.
    Villano S, Steenbergen J, Loh E.
    Future Microbiol; 2016 Oct 21; 11():1421-1434. PubMed ID: 27539442
    [Abstract] [Full Text] [Related]

  • 20. Antimicrobial susceptibility among Gram-positive and Gram-negative organisms collected from the Latin American region between 2004 and 2015 as part of the Tigecycline Evaluation and Surveillance Trial.
    Vega S, Dowzicky MJ.
    Ann Clin Microbiol Antimicrob; 2017 Jul 12; 16(1):50. PubMed ID: 28701170
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.